8-K item 3.01
Exchange deficiency notices
Open Nasdaq and NYSE listing deficiency notices and their cure deadlines as stated in the filing.
Open notices by deadline 8
| Company | Rule | Notice | Cure by | Filing |
|---|---|---|---|---|
| Borealis Foods | Market value too lowNasdaq rule 5550(b)(2) | Jul 2, 2026 | Dec 29, 2026 | 8-K item 3.01 |
| Endovia Health Sciences | Stockholders' equity too lowNYSE American rule 1003(a)(i) | Jul 8, 2026 | Jan 29, 2027 | 8-K item 3.01 |
| Borealis Foods | Late filingNasdaq rule 5250(c)(1) | Jun 30, 2026 | Feb 16, 2027 | 8-K item 3.01 |
| Aterian | Stock under $1Nasdaq rule 5550(a)(2) | Sep 2, 2026 | Mar 1, 2027 | 8-K item 3.01 |
| Hain Celestial Group | Stock under $1Nasdaq rule 5450(a)(1) | Sep 22, 2026 | Mar 22, 2027 | 8-K item 3.01 |
| Solesence | Stock under $1Nasdaq rule 5550(a)(2) | Sep 29, 2026 | Mar 29, 2027 | 8-K item 3.01 |
| Reed's | Stockholders' equity too lowNYSE American rule 1003(a)(i) | Aug 12, 2026 | Nov 29, 2027 | 8-K item 3.01 |
| Reed's | Stockholders' equity too lowNYSE American rule 1003(a)(ii) | May 29, 2026 | Nov 29, 2027 | 8-K item 3.01 |
Data through Nov 5, 2026, the newest 8-K item 3.01 SEC Tracker has read.
Dates and rules are as stated in each 8-K item 3.01 filing; a blank means the filing did not state one. Read the filing for the full terms. Not investment advice. Not affiliated with the U.S. SEC. Listing deadlines on the calendar · All screens